Percutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: study protocol for a randomized controlled trial

Background The optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic biliary drainage (PTBD) to endoscopic retrograde cholangiography (ERC) as the first intervention in patients with cholestasis due to suspected ma...

Full description

Saved in:
Bibliographic Details
Published inCurrent controlled trials in cardiovascular medicine Vol. 19; no. 1; pp. 108 - 6
Main Authors Al-Kawas, Firas, Aslanian, Harry, Baillie, John, Banovac, Filip, Buscaglia, Jonathan M., Buxbaum, James, Chak, Amitabh, Chong, Bradford, Coté, Gregory A., Draganov, Peter V., Dua, Kulwinder, Durkalski, Valerie, Elmunzer, B. Joseph, Foster, Lydia D., Gardner, Timothy B., Geller, Brian S., Jamidar, Priya, Jamil, Laith H., Keswani, Rajesh N., Khashab, Mouen A., Lang, Gabriel D., Law, Ryan, Lichtenstein, David, Lo, Simon K., McCarthy, Sean, Melo, Silvio, Mullady, Daniel, Nieto, Jose, Bayne Selby, J., Singh, Vikesh K., Spitzer, Rebecca L., Strife, Brian, Tarnaksy, Paul, Taylor, Jason R., Tokar, Jeffrey, Wang, Andrew Y., Williams, April, Willingham, Field, Yachimski, Patrick
Format Journal Article
LanguageEnglish
Published London BioMed Central 14.02.2018
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects
Online AccessGet full text
ISSN1745-6215
1745-6215
DOI10.1186/s13063-018-2473-2

Cover

Abstract Background The optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic biliary drainage (PTBD) to endoscopic retrograde cholangiography (ERC) as the first intervention in patients with cholestasis due to suspected malignant hilar obstruction (MHO). Methods The INTERCPT trial is a multi-center, comparative effectiveness, randomized, superiority trial of PTBD vs. ERC for decompression of suspected MHO. One hundred and eighty-four eligible patients across medical centers in the United States, who provide informed consent, will be randomly assigned in 1:1 fashion via a web-based electronic randomization system to either ERC or PTBD as the initial drainage and, if indicated, diagnostic procedure. All subsequent clinical interventions, including crossover to the alternative procedure, will be dictated by treating physicians per usual clinical care. Enrolled subjects will be assessed for successful biliary drainage (primary outcome measure), adequate tissue diagnosis, adverse events, the need for additional procedures, hospitalizations, and oncological outcomes over a 6-month follow-up period. Subjects, treating clinicians and outcome assessors will not be blinded. Discussion The INTERCPT trial is designed to determine whether PTBD or ERC is the better initial approach when managing a patient with suspected MHO, a common clinical dilemma that has never been investigated in a randomized trial. Trial registration ClinicalTrials.gov, Identifier: NCT03172832 . Registered on 1 June 2017.
AbstractList Background The optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic biliary drainage (PTBD) to endoscopic retrograde cholangiography (ERC) as the first intervention in patients with cholestasis due to suspected malignant hilar obstruction (MHO). Methods The INTERCPT trial is a multi-center, comparative effectiveness, randomized, superiority trial of PTBD vs. ERC for decompression of suspected MHO. One hundred and eighty-four eligible patients across medical centers in the United States, who provide informed consent, will be randomly assigned in 1:1 fashion via a web-based electronic randomization system to either ERC or PTBD as the initial drainage and, if indicated, diagnostic procedure. All subsequent clinical interventions, including crossover to the alternative procedure, will be dictated by treating physicians per usual clinical care. Enrolled subjects will be assessed for successful biliary drainage (primary outcome measure), adequate tissue diagnosis, adverse events, the need for additional procedures, hospitalizations, and oncological outcomes over a 6-month follow-up period. Subjects, treating clinicians and outcome assessors will not be blinded. Discussion The INTERCPT trial is designed to determine whether PTBD or ERC is the better initial approach when managing a patient with suspected MHO, a common clinical dilemma that has never been investigated in a randomized trial. Trial registration ClinicalTrials.gov, Identifier: NCT03172832 . Registered on 1 June 2017.
Abstract Background The optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic biliary drainage (PTBD) to endoscopic retrograde cholangiography (ERC) as the first intervention in patients with cholestasis due to suspected malignant hilar obstruction (MHO). Methods The INTERCPT trial is a multi-center, comparative effectiveness, randomized, superiority trial of PTBD vs. ERC for decompression of suspected MHO. One hundred and eighty-four eligible patients across medical centers in the United States, who provide informed consent, will be randomly assigned in 1:1 fashion via a web-based electronic randomization system to either ERC or PTBD as the initial drainage and, if indicated, diagnostic procedure. All subsequent clinical interventions, including crossover to the alternative procedure, will be dictated by treating physicians per usual clinical care. Enrolled subjects will be assessed for successful biliary drainage (primary outcome measure), adequate tissue diagnosis, adverse events, the need for additional procedures, hospitalizations, and oncological outcomes over a 6-month follow-up period. Subjects, treating clinicians and outcome assessors will not be blinded. Discussion The INTERCPT trial is designed to determine whether PTBD or ERC is the better initial approach when managing a patient with suspected MHO, a common clinical dilemma that has never been investigated in a randomized trial. Trial registration ClinicalTrials.gov, Identifier: NCT03172832. Registered on 1 June 2017.
The optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic biliary drainage (PTBD) to endoscopic retrograde cholangiography (ERC) as the first intervention in patients with cholestasis due to suspected malignant hilar obstruction (MHO).BACKGROUNDThe optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic biliary drainage (PTBD) to endoscopic retrograde cholangiography (ERC) as the first intervention in patients with cholestasis due to suspected malignant hilar obstruction (MHO).The INTERCPT trial is a multi-center, comparative effectiveness, randomized, superiority trial of PTBD vs. ERC for decompression of suspected MHO. One hundred and eighty-four eligible patients across medical centers in the United States, who provide informed consent, will be randomly assigned in 1:1 fashion via a web-based electronic randomization system to either ERC or PTBD as the initial drainage and, if indicated, diagnostic procedure. All subsequent clinical interventions, including crossover to the alternative procedure, will be dictated by treating physicians per usual clinical care. Enrolled subjects will be assessed for successful biliary drainage (primary outcome measure), adequate tissue diagnosis, adverse events, the need for additional procedures, hospitalizations, and oncological outcomes over a 6-month follow-up period. Subjects, treating clinicians and outcome assessors will not be blinded.METHODSThe INTERCPT trial is a multi-center, comparative effectiveness, randomized, superiority trial of PTBD vs. ERC for decompression of suspected MHO. One hundred and eighty-four eligible patients across medical centers in the United States, who provide informed consent, will be randomly assigned in 1:1 fashion via a web-based electronic randomization system to either ERC or PTBD as the initial drainage and, if indicated, diagnostic procedure. All subsequent clinical interventions, including crossover to the alternative procedure, will be dictated by treating physicians per usual clinical care. Enrolled subjects will be assessed for successful biliary drainage (primary outcome measure), adequate tissue diagnosis, adverse events, the need for additional procedures, hospitalizations, and oncological outcomes over a 6-month follow-up period. Subjects, treating clinicians and outcome assessors will not be blinded.The INTERCPT trial is designed to determine whether PTBD or ERC is the better initial approach when managing a patient with suspected MHO, a common clinical dilemma that has never been investigated in a randomized trial.DISCUSSIONThe INTERCPT trial is designed to determine whether PTBD or ERC is the better initial approach when managing a patient with suspected MHO, a common clinical dilemma that has never been investigated in a randomized trial.ClinicalTrials.gov, Identifier: NCT03172832 . Registered on 1 June 2017.TRIAL REGISTRATIONClinicalTrials.gov, Identifier: NCT03172832 . Registered on 1 June 2017.
BackgroundThe optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic biliary drainage (PTBD) to endoscopic retrograde cholangiography (ERC) as the first intervention in patients with cholestasis due to suspected malignant hilar obstruction (MHO).MethodsThe INTERCPT trial is a multi-center, comparative effectiveness, randomized, superiority trial of PTBD vs. ERC for decompression of suspected MHO. One hundred and eighty-four eligible patients across medical centers in the United States, who provide informed consent, will be randomly assigned in 1:1 fashion via a web-based electronic randomization system to either ERC or PTBD as the initial drainage and, if indicated, diagnostic procedure. All subsequent clinical interventions, including crossover to the alternative procedure, will be dictated by treating physicians per usual clinical care. Enrolled subjects will be assessed for successful biliary drainage (primary outcome measure), adequate tissue diagnosis, adverse events, the need for additional procedures, hospitalizations, and oncological outcomes over a 6-month follow-up period. Subjects, treating clinicians and outcome assessors will not be blinded.DiscussionThe INTERCPT trial is designed to determine whether PTBD or ERC is the better initial approach when managing a patient with suspected MHO, a common clinical dilemma that has never been investigated in a randomized trial.Trial registrationClinicalTrials.gov, Identifier: NCT03172832. Registered on 1 June 2017.
The optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic biliary drainage (PTBD) to endoscopic retrograde cholangiography (ERC) as the first intervention in patients with cholestasis due to suspected malignant hilar obstruction (MHO). The INTERCPT trial is a multi-center, comparative effectiveness, randomized, superiority trial of PTBD vs. ERC for decompression of suspected MHO. One hundred and eighty-four eligible patients across medical centers in the United States, who provide informed consent, will be randomly assigned in 1:1 fashion via a web-based electronic randomization system to either ERC or PTBD as the initial drainage and, if indicated, diagnostic procedure. All subsequent clinical interventions, including crossover to the alternative procedure, will be dictated by treating physicians per usual clinical care. Enrolled subjects will be assessed for successful biliary drainage (primary outcome measure), adequate tissue diagnosis, adverse events, the need for additional procedures, hospitalizations, and oncological outcomes over a 6-month follow-up period. Subjects, treating clinicians and outcome assessors will not be blinded. The INTERCPT trial is designed to determine whether PTBD or ERC is the better initial approach when managing a patient with suspected MHO, a common clinical dilemma that has never been investigated in a randomized trial. ClinicalTrials.gov, Identifier: NCT03172832 . Registered on 1 June 2017.
ArticleNumber 108
Audience Academic
Author Lang, Gabriel D.
Banovac, Filip
Foster, Lydia D.
Tarnaksy, Paul
Strife, Brian
Wang, Andrew Y.
Baillie, John
McCarthy, Sean
Singh, Vikesh K.
Geller, Brian S.
Spitzer, Rebecca L.
Buscaglia, Jonathan M.
Bayne Selby, J.
Williams, April
Chak, Amitabh
Willingham, Field
Draganov, Peter V.
Al-Kawas, Firas
Dua, Kulwinder
Gardner, Timothy B.
Keswani, Rajesh N.
Chong, Bradford
Law, Ryan
Aslanian, Harry
Yachimski, Patrick
Jamil, Laith H.
Durkalski, Valerie
Elmunzer, B. Joseph
Mullady, Daniel
Nieto, Jose
Lo, Simon K.
Tokar, Jeffrey
Jamidar, Priya
Khashab, Mouen A.
Lichtenstein, David
Melo, Silvio
Buxbaum, James
Coté, Gregory A.
Taylor, Jason R.
Author_xml – sequence: 1
  givenname: Firas
  surname: Al-Kawas
  fullname: Al-Kawas, Firas
  organization: Division of Gastroenterology, Johns Hopkins Sibley Memorial Hospital
– sequence: 2
  givenname: Harry
  surname: Aslanian
  fullname: Aslanian, Harry
  organization: Division of Gastroenterology, Yale University
– sequence: 3
  givenname: John
  surname: Baillie
  fullname: Baillie, John
  organization: Division of Gastroenterology, Virginia Commonwealth University
– sequence: 4
  givenname: Filip
  surname: Banovac
  fullname: Banovac, Filip
  organization: Division of Interventional Radiology, Vanderbilt University
– sequence: 5
  givenname: Jonathan M.
  surname: Buscaglia
  fullname: Buscaglia, Jonathan M.
  organization: Division of Gastroenterology, Stony Brook University
– sequence: 6
  givenname: James
  surname: Buxbaum
  fullname: Buxbaum, James
  organization: Division of Gastroenterology, University of Southern California
– sequence: 7
  givenname: Amitabh
  surname: Chak
  fullname: Chak, Amitabh
  organization: Division of Gastroenterology, Case Western Reserve University
– sequence: 8
  givenname: Bradford
  surname: Chong
  fullname: Chong, Bradford
  organization: Division of Gastroenterology, University of Southern California
– sequence: 9
  givenname: Gregory A.
  surname: Coté
  fullname: Coté, Gregory A.
  organization: Division of Gastroenterology and Hepatology, Medical University of South Carolina
– sequence: 10
  givenname: Peter V.
  surname: Draganov
  fullname: Draganov, Peter V.
  organization: Division of Gastroenterology, Hepatology, and Nutrition, University of Florida
– sequence: 11
  givenname: Kulwinder
  surname: Dua
  fullname: Dua, Kulwinder
  organization: Division of Gastroenterology, Medical College of Wisconsin
– sequence: 12
  givenname: Valerie
  surname: Durkalski
  fullname: Durkalski, Valerie
  organization: Department of Public Health Sciences, Medical University of South Carolina
– sequence: 13
  givenname: B. Joseph
  surname: Elmunzer
  fullname: Elmunzer, B. Joseph
  email: elmunzer@musc.edu
  organization: Division of Gastroenterology and Hepatology, Medical University of South Carolina
– sequence: 14
  givenname: Lydia D.
  surname: Foster
  fullname: Foster, Lydia D.
  organization: Department of Public Health Sciences, Medical University of South Carolina
– sequence: 15
  givenname: Timothy B.
  surname: Gardner
  fullname: Gardner, Timothy B.
  organization: Division of Gastroenterology, Dartmouth University
– sequence: 16
  givenname: Brian S.
  surname: Geller
  fullname: Geller, Brian S.
  organization: Division of Interventional Radiology, University of Florida
– sequence: 17
  givenname: Priya
  surname: Jamidar
  fullname: Jamidar, Priya
  organization: Division of Gastroenterology, Yale University
– sequence: 18
  givenname: Laith H.
  surname: Jamil
  fullname: Jamil, Laith H.
  organization: Division of Gastroenterology, Cedars Sinai Medical Center
– sequence: 19
  givenname: Rajesh N.
  surname: Keswani
  fullname: Keswani, Rajesh N.
  organization: Division of Gastroenterology, Northwestern University
– sequence: 20
  givenname: Mouen A.
  surname: Khashab
  fullname: Khashab, Mouen A.
  organization: Division of Gastroenterology, Johns Hopkins Medical Institutions
– sequence: 21
  givenname: Gabriel D.
  surname: Lang
  fullname: Lang, Gabriel D.
  organization: Division of Gastroenterology, Washington University
– sequence: 22
  givenname: Ryan
  surname: Law
  fullname: Law, Ryan
  organization: Division of Gastroenterology, University of Michigan
– sequence: 23
  givenname: David
  surname: Lichtenstein
  fullname: Lichtenstein, David
  organization: Division of Gastroenterology, Boston University
– sequence: 24
  givenname: Simon K.
  surname: Lo
  fullname: Lo, Simon K.
  organization: Division of Gastroenterology, Cedars Sinai Medical Center
– sequence: 25
  givenname: Sean
  surname: McCarthy
  fullname: McCarthy, Sean
  organization: Division of Gastroenterology, Ohio State University
– sequence: 26
  givenname: Silvio
  surname: Melo
  fullname: Melo, Silvio
  organization: Division of Gastroenterology, University of Florida-Jacksonville
– sequence: 27
  givenname: Daniel
  surname: Mullady
  fullname: Mullady, Daniel
  organization: Division of Gastroenterology, Washington University
– sequence: 28
  givenname: Jose
  surname: Nieto
  fullname: Nieto, Jose
  organization: The Borland-Groover Clinic
– sequence: 29
  givenname: J.
  surname: Bayne Selby
  fullname: Bayne Selby, J.
  organization: Division of Interventional Radiology, Medical University of South Carolina
– sequence: 30
  givenname: Vikesh K.
  surname: Singh
  fullname: Singh, Vikesh K.
  organization: Division of Gastroenterology, Johns Hopkins Medical Institutions
– sequence: 31
  givenname: Rebecca L.
  surname: Spitzer
  fullname: Spitzer, Rebecca L.
  organization: Division of Gastroenterology and Hepatology, Medical University of South Carolina
– sequence: 32
  givenname: Brian
  surname: Strife
  fullname: Strife, Brian
  organization: Division of Interventional Radiology, Virginia Commonwealth University
– sequence: 33
  givenname: Paul
  surname: Tarnaksy
  fullname: Tarnaksy, Paul
  organization: Division of Gastroenterology, Methodist Dallas Medical Center
– sequence: 34
  givenname: Jason R.
  surname: Taylor
  fullname: Taylor, Jason R.
  organization: Division of Gastroenterology, Saint Louis University
– sequence: 35
  givenname: Jeffrey
  surname: Tokar
  fullname: Tokar, Jeffrey
  organization: Division of Gastroenterology, Fox Chase Cancer Center
– sequence: 36
  givenname: Andrew Y.
  surname: Wang
  fullname: Wang, Andrew Y.
  organization: Division of Gastroenterology, University of Virginia
– sequence: 37
  givenname: April
  surname: Williams
  fullname: Williams, April
  organization: Division of Gastroenterology and Hepatology, Medical University of South Carolina
– sequence: 38
  givenname: Field
  surname: Willingham
  fullname: Willingham, Field
  organization: Division of Gastroenterology, Emory University
– sequence: 39
  givenname: Patrick
  surname: Yachimski
  fullname: Yachimski, Patrick
  organization: Division of Gastroenterology, Vanderbilt University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29444707$$D View this record in MEDLINE/PubMed
BookMark eNqNUstu1TAUjFARfcAHsEGW2LBJ8SPOgwVSVfGoVAkWsLZO_Ehd-drBdoouX8On4ttb2t4KEMoitjMzJzPjw2rPB6-r6jnBx4T07etEGG5ZjUlf06ZjNX1UHZCu4XVLCd-7t96vDlO6xLhhA2ueVPt0aJqmw91B9fOzjnLJ4HVYEsoRfLrQM2Qr0VU6RtqrkGSYyzbqHMMUQWk0WmchrpGKYD1MGpkQUVrSrGXWCq3A2cmDz-jCOogojCnHRWYb_BuU8qLWaI4hBxncNRNQGavCyv4oZBl8meNcWeZowT2tHhtwST-7eR9VX9-_-3L6sT7_9OHs9OS8li1muVYMG8kM1lwaOQAfW2WIGUHJjjPeQs-YHCSRGtgwSKCSNAa3ctDUyHYYMDuqzra6KsClmKNdFYcigBXXByFOAmKJxWkBpqedGhjhzdgA4SDHtm-pNlhpxtqhaNGt1uJnWH8H524FCRab6sS2OlGqE5vqBC2kt1vSvIwrraQuOYDb-ZPdL95eiClcCd4Txq4dvLoRiOHbolMWK5ukdm5brqAY06ZnlLcF-vIB9DIs0Zd8Be0GzgjhmN-hJiiurTehzJUbUXHCmxb3tCcb1PEfUOVRemVLm9rYcr5DeHHf6K3D35eyALotQMaQUtRGSJthc32KsnX_zJA8YP5P7jdlpYL1k453Wfyd9As9HxlS
CitedBy_id crossref_primary_10_1016_j_crad_2019_03_012
crossref_primary_10_1016_j_giec_2018_12_001
crossref_primary_10_1016_j_cpsurg_2020_100854
crossref_primary_10_17116_hirurgia20200615
crossref_primary_10_1007_s10620_020_06249_8
crossref_primary_10_1007_s00464_022_09413_5
crossref_primary_10_1007_s00270_024_03778_x
crossref_primary_10_1016_j_cgh_2020_05_035
crossref_primary_10_1007_s10620_018_5337_4
crossref_primary_10_1016_j_hpb_2022_10_009
crossref_primary_10_1016_j_gie_2020_12_035
crossref_primary_10_4103_eus_eus_59_20
crossref_primary_10_1007_s12262_020_02270_3
crossref_primary_10_1177_0003134820923287
crossref_primary_10_1016_S2468_1253_18_30234_6
Cites_doi 10.1016/j.gie.2016.06.051
10.1016/j.jvir.2010.01.012
10.1016/j.gie.2008.04.005
10.1111/jgh.12128
10.1007/s11605-009-1009-1
10.1016/j.hpb.2016.03.002
10.1055/s-0034-1392559
ContentType Journal Article
Copyright The Author(s). 2018
COPYRIGHT 2018 BioMed Central Ltd.
The Author(s). 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s). 2018
– notice: COPYRIGHT 2018 BioMed Central Ltd.
– notice: The Author(s). 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor In alphabetical order for the INTERCPT Study Group and the United States Cooperative for Outcomes Research in Endoscopy (USCORE)
CorporateAuthor_xml – name: In alphabetical order for the INTERCPT Study Group and the United States Cooperative for Outcomes Research in Endoscopy (USCORE)
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1186/s13063-018-2473-2
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central
ProQuest Health & Medical Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Open Access - DOAJ
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Openly Available Collection - DOAJ
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 6
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1745-6215
EndPage 6
ExternalDocumentID oai_doaj_org_article_af827d93154b4a15acb6862ef0de3369
10.1186/s13063-018-2473-2
PMC5813390
A546082815
29444707
10_1186_s13063_018_2473_2
Genre Clinical Trial Protocol
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: P30 DK058404
– fundername: NCATS NIH HHS
  grantid: UL1 TR001863
GroupedDBID ---
0R~
123
2-G
29Q
2WC
53G
5VS
6PF
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACUHS
ADBBV
ADRAZ
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHYZX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NAPCQ
O5R
O5S
OVT
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
WOQ
WOW
~8M
AAYXX
CITATION
-5E
-5G
-A0
-BR
ACRMQ
ADINQ
ALIPV
C24
CGR
CUY
CVF
ECM
EIF
NPM
3V.
5GY
7XB
8FK
AHMBA
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
XSB
7X8
5PM
2VQ
4.4
ADTOC
AHSBF
C1A
IPNFZ
RIG
UNPAY
ID FETCH-LOGICAL-c603t-d30fc3f0e5cfc9a5b6df1fbadc75356a833c9c1cea399ca2c14f06c9e2fc69903
IEDL.DBID BENPR
ISSN 1745-6215
IngestDate Fri Oct 03 12:45:14 EDT 2025
Sun Oct 26 04:04:06 EDT 2025
Tue Sep 30 16:48:53 EDT 2025
Fri Sep 05 10:43:55 EDT 2025
Sun Oct 19 01:31:56 EDT 2025
Mon Oct 20 22:21:35 EDT 2025
Mon Oct 20 16:07:50 EDT 2025
Thu Jan 02 23:02:23 EST 2025
Wed Oct 01 04:40:32 EDT 2025
Thu Apr 24 23:09:18 EDT 2025
Sat Sep 06 07:26:37 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Endoscopic retrograde cholangiopancreatography
Cholangiocarcinoma
Percutaneous transhepatic biliary drainage
Hilar stricture
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c603t-d30fc3f0e5cfc9a5b6df1fbadc75356a833c9c1cea399ca2c14f06c9e2fc69903
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
content type line 23
OpenAccessLink https://www.proquest.com/docview/2795311505?pq-origsite=%requestingapplication%&accountid=15518
PMID 29444707
PQID 2795311505
PQPubID 44365
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_af827d93154b4a15acb6862ef0de3369
unpaywall_primary_10_1186_s13063_018_2473_2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5813390
proquest_miscellaneous_2002483256
proquest_journals_2795311505
gale_infotracmisc_A546082815
gale_infotracacademiconefile_A546082815
pubmed_primary_29444707
crossref_citationtrail_10_1186_s13063_018_2473_2
crossref_primary_10_1186_s13063_018_2473_2
springer_journals_10_1186_s13063_018_2473_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-02-14
PublicationDateYYYYMMDD 2018-02-14
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-14
  day: 14
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Current controlled trials in cardiovascular medicine
PublicationTitleAbbrev Trials
PublicationTitleAlternate Trials
PublicationYear 2018
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References JK Wiggers (2473_CR6) 2015; 47
JJ Kloek (2473_CR2) 2010; 14
R Rerknimitr (2473_CR4) 2013; 28
WE Saad (2473_CR5) 2010; 21
A Hameed (2473_CR3) 2016; 18
WH Paik (2473_CR1) 2009; 69
V Chandrasekhara (2473_CR7) 2017; 85
References_xml – volume: 85
  start-page: 32
  year: 2017
  ident: 2473_CR7
  publication-title: Gastrointest Endosc.
  doi: 10.1016/j.gie.2016.06.051
– volume: 21
  start-page: 789
  year: 2010
  ident: 2473_CR5
  publication-title: J Vasc Interv Radiol.
  doi: 10.1016/j.jvir.2010.01.012
– volume: 69
  start-page: 55
  year: 2009
  ident: 2473_CR1
  publication-title: Gastrointest Endosc.
  doi: 10.1016/j.gie.2008.04.005
– volume: 28
  start-page: 593
  year: 2013
  ident: 2473_CR4
  publication-title: J Gastroenterol Hepatol.
  doi: 10.1111/jgh.12128
– volume: 14
  start-page: 119
  year: 2010
  ident: 2473_CR2
  publication-title: J Gastrointest Surg.
  doi: 10.1007/s11605-009-1009-1
– volume: 18
  start-page: 400
  year: 2016
  ident: 2473_CR3
  publication-title: HPB (Oxford).
  doi: 10.1016/j.hpb.2016.03.002
– volume: 47
  start-page: 1124
  year: 2015
  ident: 2473_CR6
  publication-title: Endoscopy.
  doi: 10.1055/s-0034-1392559
SSID ssj0043934
ssj0017864
Score 2.2566454
Snippet Background The optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic...
The optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic biliary...
BackgroundThe optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous transhepatic...
Abstract Background The optimal approach to the drainage of malignant obstruction at the liver hilum remains uncertain. We aim to compare percutaneous...
SourceID doaj
unpaywall
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 108
SubjectTerms Bile Duct Neoplasms - complications
Bile Duct Neoplasms - diagnostic imaging
Biomedicine
Cancer therapies
Cholangiocarcinoma
Cholangiopancreatography, Endoscopic Retrograde - adverse effects
Cholangitis
Cholestasis - diagnostic imaging
Cholestasis - etiology
Cholestasis - therapy
Clinical medicine
Comparative analysis
Comparative Effectiveness Research
Consent
Contraindications
Decision making
Drainage - adverse effects
Drainage - methods
Endoscopic retrograde cholangiopancreatography
Endoscopy
Enrollments
Equivalence Trials as Topic
Health Sciences
Hilar stricture
Humans
Intervention
Liver
Medical records
Medical referrals
Medicine
Medicine & Public Health
Multicenter Studies as Topic
Patient outcomes
Patients
Percutaneous transhepatic biliary drainage
Physicians
Regulatory approval
Statistics for Life Sciences
Study Protocol
Time Factors
Treatment Outcome
Ultrasonic imaging
United States
SummonAdditionalLinks – databaseName: Open Access - DOAJ
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxRBEG4kBx8H8Z3RKC0IgmFMz_RjZrxFMQQh4sFAbk0_3YXNbNiHEn-NP9WqntlxRyG5eNvd7manp76uB131FSGvamznUCmTe2ZjLoQIuXGqzJmtCuuaxtoCa4dPPqvjU_HpTJ5ttfrCnLCOHrh7cQcm1mXlGw6m3gpTSOMsFjWEyHzgXKXSPVY3m2Cq08FgZbno7zCLWh0sQVPjfWUBqBAVz8uRFUpk_f-q5C2b9He-5HBpeofcWrcX5vKHmc227NLRPXK3dyjpYbeR--RGaB-Qmyf9lflD8utLWLg1uIABYny6QtM0CZhG7ej35VsaWj_HyhT4ugirlKzlA8WMWbO4pB4bSIDGoeDa0uU6lWUGT8_Bef-GGTR0MoXImM7tQEP7jibCWor8D3MAWVppKPytn59Pf8LiPjl-Bh9Ty5BH5PTo49cPx3nfliF3ivFV7jmLjkcWpIuuMdIqH4tojXcQ-khlas5d4woXDDg_zpSuEJEp14QyOgXGjz8mO-28DbuEWljrRRWlk15YFizEUwbJSr0Ito4-I2wjJu16znJsnTHTKXaple4kq0GyGiWry4y8GZZcdIQdV01-j7IfJiLXdvoBEKh7BOrrEJiR14gcjRoBHs6ZvrABtojcWvpQCoVEgYXMyN5oJpxkNx7eYE_3mmSpy6qRyIjEYPjlMIwrMTsuYQdbiZYCVLNUGXnSQXXYUtnAAaxYlZFqBOLRnscj7XSSeMZlXXDesIzsb-D-57GueKX7w4m4XgBP_4cAnpHbJR5tbNMj9sgOID48B1dxZV8krfAbILhong
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwELbGkHj5gHgnMJCREEhMGU5iOwkSQgMxTUhFfKDSvkV-XSt1SdcXoPwafip3bhoWmAbf2tpuYt-d76w7Pw8hzwqkc8ilii3TPuacu1gZmcZM54k2Zal1gneHB5_k4ZB_PBJHW2STPW8XcH7u0Q75pIazyd7309VbMPg3weAL-WoO-zBmIxOQOc-zOH0-PY2RVwrzry3JxiVyGXxXieQOA97lGcAbr_POORexBO_X5j3P_dee5woA_39v42f82J81ll2i9Tq5uqynavVNTSZnfNnBTXKjDULp_lprbpEtV98mVwZtmv0O-fnZzcwSwkbXLOd0ge5s5LD02tCv8z3qatvgbRb4OnOLUOBlHcUqWzVbUYukE7BLUQiH6XwZrnI6S08g4D_Gqhs6GsOS00Z30LWvaQC5pYgZ0YBihpGKwmNtczL-AYPbgvoJfAw0I3fJ8ODDl_eHcUvlEBvJskVsM-ZN5pkTxptSCS2tT7xW1sBxSUhVZJkpTWKcgoDJqNQk3DNpSpd6I8FhZvfIdt3U7gGhGsZannthhOWaOQ1nMIUAp5Y7XXgbEbYRU2VanHOk25hU4bxTyGot2QokW6FkqzQiL7sh0zXIx0Wd36Hsu46Izx1-aGbHVWvulfJFmtsygwBVc5UIZTRexXGeWZdlsozIC9ScCvUaXs6o9jIETBHxuKp9wSWCCyYiIju9nmD9pt-80b1qYzxVmpcCUZQYND_tmnEkVtQF3UH60ZTDdi5kRO6vVbWbUlqC0eYsj0jeU-LenPst9XgUsMlFkWRZySKyu1H33691wZLudhbxbwE8_I85PSLXUrRcZO7hO2QbFNo9huhxoZ-EDeAX8JVuVA
  priority: 102
  providerName: Scholars Portal
– databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZaxRBEG4kgseDeDsapQVBMIz2TB8z49sqhiBEfDCQt6bP7MJmJuyhxF_jT7Wqd2bMqkR8293u2p3euumqrwh5UeM4h0qZ3DMbcyFEyI1TZc5sVVjXNNYW2Dt8-EkdHImPx_K47-NeDtXuw5VkstRJrWv1ZgnWFu8cC-CsqHgOdveqRDQvEOKjcjKYX3CwXPTXl38l23JACaf_T2t8wR39Xio53pfeJNfX7Zk5_2bm8wsuaf82udXHknSyYf4dciW0d8m1w_62_B758Tks3BqivwDpPV2hV5oGrKB29OvyNQ2t77ApBd4uwirVaflAsVjWLM6px9kRYGwoRLV0uU4dmcHTU4jbT7B4hk5nkBTTzo4ItG9pwqqlCP3QgXwlSkPhZ313OvsOxH1d_Bxepmkh98nR_ocv7w_yfiJD7hTjq9xzFh2PLEgXXWOkVT4W0RrvIOuRytScu8YVLhiIe5wpXSEiU64JZXQK_B5_QHbarg2PCLVA60UVpZNeWBYspFIGcUq9CLaOPiNsYJN2PVw5Ts2Y65S21EpvOKuBsxo5q8uMvBpJzjZYHZdtfoe8HzcizHb6oFuc6F5rtYl1WfmGQ5xphSmkcRY7akJkPnCumoy8RMnRaAzg4ZzpexrgiAirpSdSKMQILGRGdrd2ghK77eVB9nRvRJa6rBqJYEgMlp-Py0iJhXFJdnCKaCnAKkuVkYcbUR2PVDagexWrMlJtCfHWmbdX2tk0QYzLuuC8YRnZG8T912Nd8pfujRrxbwY8_q_vfkJulKjDOIpH7JIdEO3wFMLBlX2W1P8nkG1ciw
  priority: 102
  providerName: Springer Nature
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Za9tAEF5KAj0eeh9q07KFQqFBjo7dldQ3tzSEQkIeakifxJ6xiSIZy25Jfk1_amckWbXSklLom-zdxd7RN8eyM98Q8ibFdg6JkL4JlPMZY9aXWkR-oJJQ6SxTKsTa4cMjcTBhn0_4SdcOqG4yZFHsnRxHmyXoRWO34UGf7c2Na9U9FXs1WGG8iwzhjbMk9sEebwsOgfkW2Z4cHY-_tiWR3Bfg3bp7zT-uG3imhsD_dzO94aeu5lD2F6l3yK1VOZcX32VRbPiq_XukWO-yTVE5G62WaqQvrxBA_icx3Cd3u5iWjlsQPiA3bPmQ3Dzsbu0fkR_HdqFXEIXaalXTJXrHqcVMbk2_1SNqS1NhcQx8XNhlky9mLMWkXbm4oAZ7WIDRoxBd03rVVIZaQ8_h_HCKSTx0OoPDOa1Uz4T7njacuRQpKCrAebNSUvhZU53PLmFxl59fwGMjgsdksv_py8cDv-sM4WsRxEvfxIHTsQss105nkithXOiUNBpOX1zINI51pkNtJcRfWkY6ZC4QOrOR0wL8b_yEbJVVaZ8RqmCtYYnjmhumAqsAORL5Ug2zKnXGI8EaFbnuaNOxe0eRN8enVOSt5HOQfI6SzyOPvOuXzFvOkOsmf0Co9ROR7rv5olqc5p31yKVLo8RkMcS7ismQS62wsse6wNg4FplH3iJQczRKCA3Z1VbAFpHeKx9zJpCrMOQe2RnMBGOih8NrqOcd-uo8SjKOpEwBDL_uh3ElJug12MFuphED78CFR562mtFvKcrABiRB4pFkoDODPQ9Hytm0oTrnaRjHWeCR3bV2_fpb14h0t1fAv7-A5_80-wW5HaGOYUsgtkO2ANr2JYSlS_WqMzc_AXd7i9E
  priority: 102
  providerName: Unpaywall
Title Percutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: study protocol for a randomized controlled trial
URI https://link.springer.com/article/10.1186/s13063-018-2473-2
https://www.ncbi.nlm.nih.gov/pubmed/29444707
https://www.proquest.com/docview/2795311505
https://www.proquest.com/docview/2002483256
https://pubmed.ncbi.nlm.nih.gov/PMC5813390
https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-018-2473-2
https://doaj.org/article/af827d93154b4a15acb6862ef0de3369
UnpaywallVersion publishedVersion
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMed Central Open Access Free
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: RBZ
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAFT
  databaseName: Colorado Digital library
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017864
  issn: 1745-6215
  databaseCode: KQ8
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Colorado Digital library
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: KQ8
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: Openly Available Collection - DOAJ
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: DOA
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: Academic Search Ultimate (ASU) - EBSCO
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: ABDBF
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: DIK
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017864
  issn: 1745-6215
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: M~E
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: RPM
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: 7X7
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: BENPR
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: M48
  dateStart: 20060401
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVAVX
  databaseName: HAS SpringerNature Open Access 2022
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: AAJSJ
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: C6C
  dateStart: 20000104
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: U2A
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3ra9swEBdtAnt8GHvPWxc0GAxWvPohyfZgjDS0K4OEMBbIPhm93ARSO8tjo_tr9qfuTnHcZoPui4gtCVu5h06-u98R8jrFcg6JkL4JVOEzxqwvtYj8QCWh0lmmVIi5w_2BOBuxz2M-3iODbS4MhlVudaJT1KbS-I38KEoyjsgwAf84_-5j1Sj0rm5LaMi6tIL54CDG9kk7QmSsFmkfnwyGXxq_QpIKVvs2w1QcLUGDox8zBG5hSexHO7uTA_H_V1Vf26v-jqNsnKl3ye11OZeXP-Vsdm2_Or1P7tWGJu1uOOMB2bPlQ3KrX7vSH5HfQ7vQazANLZz96Qq3rInF8GpNfyzfUVuaCjNW4HJhVy6Iy1iKkbRycUkNFpYATUTB5KXLtUvXtIZegFF_jpE1dDKFEzOtVANP-546IFuKuBAVMJ-bKSk81lQX018wuQ6an8FPV0rkMRmdnnztnfl1uQZfiyBe-SYOCh0XgeW60JnkSpgiLJQ0Go5EXMg0jnWmQ20lGEVaRjpkRSB0ZqNCC9gU4yekVValfUaogrmGJQXX3DAVWAXnLIkgpoZZlRbGI8GWTLmuscyxpMYsd2eaVOQbyuZA2Rwpm0ceedtMmW-APG4afIy0bwYiBre7US3O81qkc1mkUWKyGIxQxWTIpVaYbmOLwNg4FplH3iDn5Kgp4OW0rBMeYImIuZV3ORMIIBhyjxzsjAQJ17vdW97Law2zzK_kwSOvmm6ciVFzjnewxGjEQGVz4ZGnG1ZtlhRlIJhJkHgk2WHinTXv9pTTicMf52kYx1ngkcMtu1-91g1_6WEjEf8nwPObl_yC3IlQaLEwDzsgLeBl-xKMw5XqkP1knHRquYernuh13IcWaD-NQ2j7LIV2FMGd9mgw7H77A2bIbZs
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEF6VVqLwgLgxFFgkEBKVqe09bCNVqIVWKT1UoVbq27KXm0hpHHJQhV_DL-G3MeM4bgNSeepbnN21vZnZOTIz3xDyOsN2DqnUoYtMEXLOfaitTMLIpLGxeW5MjLXD-weydcy_nIiTBfJ7VguDaZUzmVgJalda_I98LUlzgcgwkfjY_x5i1yiMrs5aaOi6tYJbryDG6sKOXT85BxduuL7zGej9Jkm2t44-tcK6y0BoZcRGoWNRYVkReWELm2thpCviwmhnwZIXUmeM2dzG1mvQ5VYnNuZFJG3uk8JKkOUM7nuDLHHGc3D-lja3Dg6_NnGMNJO8jqXGmVwbgsbAuGkM3MlTFiZz2rBqGvCvarikG__O22yCt7fJ8rjX15Nz3e1e0o_bd8md2rClG1NOvEcWfO8-ublfh-4fkF-HfmDHYIr6cjykI1SRbY_p3Jb-GL6nvudKrJCBy4EfVUljzlPM3NWDCXXYyAIkHwUTmw7HVXmod_QMnIhTzOSh7Q546LQ0DRzuB1oB51LEoSiB2auVmsJjXXnW-QmL6yT9LnysWpc8JMfXQrhHZLFX9vwTQg2sdTwthBWOm8gb8Os0gqY67k1WuIBEMzIpW2OnYwuPrqp8qEyqKWUVUFYhZVUSkHfNkv4UOOSqyZtI-2YiYn5XX5SDU1WLEKWLLEldzsDoNVzHQluD5T2-iJxnTOYBeYuco1AywctZXRdYwBYR40ttCC4RsDAWAVmZmwkSxc4Pz3hP1RJtqC7OX0BeNcO4ErP0Kt7BlqYJBxUhZEAeT1m12VKSgyBIozQg6RwTz-15fqTXaVd45yKLGcujgKzO2P3ita74SVebE_F_Ajy9essvyXLraH9P7e0c7D4jtxI8wNgUiK-QReBr_xwM05F5UZ9-Sr5dt8D5A6ktpdg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2VIhV4QNwxFFgkEBKViS-7axsJoUKJWkqrPlApb8tem0hpHHKhCl_Dd_B1zDiO24AUnvqWZL2xN3N2LtmZM4S8yLGdQyZUaCPtQ8aYC5URSRjpLNamKLSOsXb44FDsHrPPHd5ZI78XtTCYVrnQiZWitqXB_8hbSVZwZIaJeMvXaRFHO-33w-8hdpDCk9ZFO405RPbd7AzCt_G7vR2Q9cskaX_6-nE3rDsMhEZE6SS0aeRN6iPHjTeF4lpYH3utrAEvnguVp6kpTGycAjtuVGJi5iNhCpd4I0CPp_C9V8jVLE0LTCfMOk2wF2e5YPUpapyL1hhsBZ6YxoBLlqVhsmQHq3YB_xqFC1bx74zN5tj2Brk2HQzV7Ez1-xcsY_sWuVm7tHR7jsHbZM0N7pCNg_rQ_i75deRGZgpOqCunYzpB49h1mMht6I_xG-oGtsTaGHg7cpMqXcw6ijm7ajSjFltYgM6j4FzT8bQqDHWWnkL4cII5PLTbg9iclrohwn1LK8pcigwUJcC8mqko3NaWp72fMLlOz-_Dy6ppyT1yfCliu0_WB-XAPSRUw1zLMs8Nt0xHTkNEp5Au1TKnc28DEi3EJE3Nmo7NO_qyip5yIeeSlSBZiZKVSUBeN1OGc8qQVRd_QNk3FyLbd_VBOTqRtfKQyudJZosU3F3NVMyV0VjY43xkXZqKIiCvEDkSdRI8nFF1aQUsEdm95DZnAqkKYx6QzaUrQZeY5eEF9mSty8byfOcF5HkzjDMxP6_CDjYzTRgYBy4C8mAO1WZJSQEqIIuygGRLIF5a8_LIoNetmM55HsPWigKytYD7-WOt-Em3mh3xfwE8Wr3kZ2QD1Iz8sne4_5hcT3D_YjcgtknWAdbuCXikE_202vqUfLtsXfMHMg6jcg
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Za9tAEF5KAj0eeh9q07KFQqFBjo7dldQ3tzSEQkIeakifxJ6xiSIZy25Jfk1_amckWbXSklLom-zdxd7RN8eyM98Q8ibFdg6JkL4JlPMZY9aXWkR-oJJQ6SxTKsTa4cMjcTBhn0_4SdcOqG4yZFHsnRxHmyXoRWO34UGf7c2Na9U9FXs1WGG8iwzhjbMk9sEebwsOgfkW2Z4cHY-_tiWR3Bfg3bp7zT-uG3imhsD_dzO94aeu5lD2F6l3yK1VOZcX32VRbPiq_XukWO-yTVE5G62WaqQvrxBA_icx3Cd3u5iWjlsQPiA3bPmQ3Dzsbu0fkR_HdqFXEIXaalXTJXrHqcVMbk2_1SNqS1NhcQx8XNhlky9mLMWkXbm4oAZ7WIDRoxBd03rVVIZaQ8_h_HCKSTx0OoPDOa1Uz4T7njacuRQpKCrAebNSUvhZU53PLmFxl59fwGMjgsdksv_py8cDv-sM4WsRxEvfxIHTsQss105nkithXOiUNBpOX1zINI51pkNtJcRfWkY6ZC4QOrOR0wL8b_yEbJVVaZ8RqmCtYYnjmhumAqsAORL5Ug2zKnXGI8EaFbnuaNOxe0eRN8enVOSt5HOQfI6SzyOPvOuXzFvOkOsmf0Co9ROR7rv5olqc5p31yKVLo8RkMcS7ismQS62wsse6wNg4FplH3iJQczRKCA3Z1VbAFpHeKx9zJpCrMOQe2RnMBGOih8NrqOcd-uo8SjKOpEwBDL_uh3ElJug12MFuphED78CFR562mtFvKcrABiRB4pFkoDODPQ9Hytm0oTrnaRjHWeCR3bV2_fpb14h0t1fAv7-A5_80-wW5HaGOYUsgtkO2ANr2JYSlS_WqMzc_AXd7i9E
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Percutaneous+transhepatic+vs.+endoscopic+retrograde+biliary+drainage+for+suspected+malignant+hilar+obstruction%3A+study+protocol+for+a+randomized+controlled+trial&rft.jtitle=Current+controlled+trials+in+cardiovascular+medicine&rft.au=Al-Kawas%2C+Firas&rft.au=Aslanian%2C+Harry&rft.au=Baillie%2C+John&rft.au=Banovac%2C+Filip&rft.date=2018-02-14&rft.pub=Springer+Nature+B.V&rft.eissn=1745-6215&rft.volume=19&rft.issue=1&rft.spage=108&rft_id=info:doi/10.1186%2Fs13063-018-2473-2&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-6215&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-6215&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-6215&client=summon